Long-term Follow-up of Checkpoint Inhibitors-induced Ileo-colitis

Clinical trial NCT06899789 · RECRUITING

Trial details

NCT number: NCT06899789
Sponsor: Fondazione IRCCS Policlinico San Matteo di Pavia
Status: RECRUITING
Study type: OBSERVATIONAL

Immune Checkpoint Inhibitors-induced Colitis Advanced Melanoma Skin Cancer, Non-small Cell Lung Carcinoma, Kidney Adenocarcinoma Ileo-colitis Immune Mediated-colitis

Start date: 2022-07-29
Primary completion: 2025-12-31
Enrollment: 250

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.